Clinical Trial

Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France

Study acronym: MRC-Gard
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2016-10-18; most recent amendment 2025-03-07.
Status change: Not Yet Recruiting → Recruiting 2019-11-07
Trial Details
NCT Number NCT02938611
Lead Sponsor Centre Hospitalier Universitaire de Nīmes
Conditions Renal Insufficiency, Chronic
Enrollment 3,375 participants
Start Date 2019-01-01
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-10